Breast Cancer Research & Treatment Issues Research Articles in Vol. 195, No. 2
August 13, 2022
August 13, 2022
BASEL, Switzerland, Aug. 13 -- Breast Cancer Research and Treatment, a peer-reviewed journal, published research articles on the following topics in its Vol. 195, No. 2 edition:
Preclinical study:
* Intermedin (adrenomedullin 2) promotes breast cancer metastasis via Src/c-Myc-mediated ribosome production and protein translation
* MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC in . . .
Preclinical study:
* Intermedin (adrenomedullin 2) promotes breast cancer metastasis via Src/c-Myc-mediated ribosome production and protein translation
* MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC in . . .